| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11596-008-0508-8 |
| P698 | PubMed publication ID | 18846331 |
| P2093 | author name string | Ping Zou | |
| Juan Zhao | |||
| Yong You | |||
| Qiubai Li | |||
| Ke Yu | |||
| Zhichao Chen | |||
| Xiaolong Tian | |||
| Fancong Kong | |||
| P2860 | cites work | [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma] | Q81666060 |
| Suppressed NF-kB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-a induced apoptosis in human cancer cells | Q23921490 | ||
| Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms | Q23924029 | ||
| Proliferation inhibiting and apoptosis inducing effects of parthenolide on human multiple myeloma cells | Q30827663 | ||
| Treatment of multiple myeloma | Q33544882 | ||
| Bone marrow angiogenesis and progression in multiple myeloma. | Q34292940 | ||
| The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase | Q34517140 | ||
| Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. | Q34556749 | ||
| Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis | Q40377374 | ||
| New perspectives in clinical oncology from angiogenesis research | Q41372777 | ||
| TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells | Q43821708 | ||
| Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide | Q44085055 | ||
| Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation | Q47745076 | ||
| Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma | Q57009914 | ||
| Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma | Q57010218 | ||
| Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy | Q57010525 | ||
| Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma | Q58906620 | ||
| Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma | Q60652055 | ||
| Matrilysin is associated with progression of colorectal tumor | Q71768421 | ||
| Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma | Q74624015 | ||
| Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies | Q78109212 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 525-530 | |
| P577 | publication date | 2008-10-10 | |
| P1433 | published in | Journal of Huazhong University of Science and Technology. Medical Sciences | Q15711092 |
| P1476 | title | Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism | |
| P478 | volume | 28 |
| Q38864359 | Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6. |
| Q39092065 | Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion |
| Q39255458 | Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells |
Search more.